Matches in Nanopublications for { ?s ?p "[Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_assertion description "[Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206497.RAs4ExW3XbUH9s13edVQfEiEtNvlR4fOWwoAJNDZqTtF4130_provenance.
- assertion description "[Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP561206.RAfeV7UMrDhsv5n_IVZXSOAoPLmpPtII208xy2jIy4GGc130_assertion description "[Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561206.RAfeV7UMrDhsv5n_IVZXSOAoPLmpPtII208xy2jIy4GGc130_provenance.
- NP561207.RAIoU5U8POUxdnRq4NdkMQMMcHJb-6IpzUzch-EGIRjGw130_assertion description "[Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561207.RAIoU5U8POUxdnRq4NdkMQMMcHJb-6IpzUzch-EGIRjGw130_provenance.